SB1270 adds a new section to the Public Health Service Act that governs human bodies and body parts donated or transferred for education, research, or the advancement of medical, dental, or mortuary science when not intended for transplantation. The bill requires persons who acquire and sell whole bodies or parts for profit in interstate commerce to register with HHS, maintain detailed records, permit inspections, and follow federal labeling, packaging, and disposition rules.
The measure aims to reduce unregulated commercial markets and strengthen provenance and respectful disposition practices while carving out exemptions for the organ procurement network, funeral professionals, academic programs, and non‑profit entities that do not sell. It creates new compliance obligations, funding and inspection levers for HHS, and criminal penalties for falsifying labels or otherwise violating the statute.
At a Glance
What It Does
The bill requires for‑profit sellers of whole human bodies or body parts that operate across state lines to register with the Secretary of HHS, submit application details, and pay fees tied to enforcement costs. Registrants must keep case records, label and package material to federal standards, allow HHS inspections, and follow prescribed disposition rules.
Who It Affects
Primary compliance targets are commercial body brokers, anatomical suppliers, and any person who acquires and sells human remains or parts for profit in interstate commerce. Secondary impacts reach academic anatomy programs, research labs, funeral service providers, organ procurement organizations, couriers, and state medical and health regulators.
Why It Matters
This is the first federal effort to standardize provenance, labeling, and disposition for non‑transplant body donations across state lines, addressing gaps that have enabled opaque commercial transactions and cross‑border transfers. Compliance and enforcement will change how suppliers, educators, and researchers document and transport human material.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB1270 inserts a new statutory section that creates a federal registration regime for anyone who acquires and then sells whole human bodies or body parts for profit in interstate commerce. Registration requires applicants to identify business names and locations, describe premises and equipment, name an authorized representative, and promise cooperation with inspections, recordkeeping, labeling, packaging, and privacy limitations.
The Secretary of HHS sets fees annually to cover enforcement costs, but collections are subject to appropriations.
The bill specifies detailed recordkeeping obligations. For each acquisition a registrant must document that the donor knowingly consented to transfer (for non‑transplant purposes), that the donor was informed about disposition obligations, the date and time of transfer, prior possessors (such as hospitals, coroners, funeral homes, organ procurement organizations, or tissue banks), a description of the material, medical history including autopsy reports if available, and how the material was used and ultimately disposed.
HHS will write regulations filling in any additional required fields and retention periods.Labeling and packaging are central compliance points. Labels must be affixed beneath outer packaging and include items the bill lists (donor name, contents and parts, originator name and registration/licensing info, tissue types, cause of death if known, serologic results, presence of radioactives or implants, known infectious agents, PPE/universal precautions language, and a clear 'not for transplantation' statement).
Packaging must mitigate contamination, prevent leakage, reduce safety hazards, seal effectively, and preserve integrity during transport.The statute limits the use and disclosure of individually identifiable donor information to purposes the Secretary explicitly authorizes by regulation, and it requires registrants to ensure proper disposition—either returning remains to the person with legal control for burial or following their written instructions, or contracting with a transferee to assume disposition obligations. HHS is authorized to inspect registered premises at regular intervals and may suspend or revoke registration for violations; falsifying or altering required label information is a criminal violation punishable under title 18 and the statute also cross‑references fines.
The law excludes certain actors (the Organ Procurement and Transplantation Network, funeral service professionals for preparatory and disposition tasks, and non‑profit educational and research entities that do not sell) and exempts blood drawn for medical purposes and growing cell lines from the definition of 'human body part.'The bill becomes applicable two years after enactment, giving regulated entities and HHS time to draft implementing regulations, set fee schedules, and prepare inspection protocols.
The Five Things You Need to Know
The registration duty attaches only to persons who acquire human bodies and then sell a whole body or body part for profit in interstate commerce; purely educational or non‑selling institutions are excluded.
Labels must be affixed beneath the outer packaging and include the donor’s proper name, a parts list, the transferor’s contact and license/registration number, tissue types, cause of death (if known), serology results (if any), presence of radioactives/implants, known infectious agents, PPE guidance, and the statement 'not for transplantation.', Records for each acquisition must document donor informed consent for non‑transplant transfer, the donor’s medical history (including autopsy report if done), prior possessors, the date/time of transfer, how the material was used, and the final disposition.
The Secretary will set registration and renewal fees annually to match projected costs of implementation and inspections, but those fee collections are available for obligation only to the extent provided in appropriations acts.
Violations carry criminal exposure under title 18 for falsifying label information, and HHS may suspend or revoke a registrant’s registration for other statutory breaches.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Who must register and what the application requires
This subsection imposes registration on anyone who acquires and sells whole bodies or body parts for profit in interstate commerce and lays out the baseline application contents: business names, start dates, list of addresses, equipment/premises description, services provided, an adult authorized representative, and assurances on inspections, records, labeling, and privacy. The Secretary gets authority to define additional application items by regulation and to require renewal and 30‑day notice of any changes, creating an ongoing administrative relationship between HHS and registrants.
Carved‑out actors and activities
The statute explicitly exempts the Organ Procurement and Transplantation Network and its members, funeral service professionals for preparation/transport/disposition activities, and schools or non‑selling research/training organizations. That limits the reach of the federal regime to commercial sellers while preserving existing state and sectoral practices for organ transplantation and funeral services, but the text leaves room for regulatory interpretation at the margins (for example, when a funeral home sells a part commercially).
HHS inspection authority and detailed provenance records
HHS must inspect registered premises at intervals to be prescribed by regulation. Registrants must keep a separate case record for each acquisition, with prescribed fields including donor consent, informed notice about disposition, medical history/autopsy reports, chain of custody, prior possessors, and documentation of use and final disposition. These provisions aim to create an auditable provenance trail but will require registrants to integrate consent, clinical, and logistical records systems.
Specific label contents, placement, and packaging criteria
Labels must be affixed beneath outer packaging and include a long checklist of data points (donor name, contents, transferor identity and licensing, tissue types, cause of death, serology, radioactives/implants, infectious agents, PPE guidance, and 'not for transplantation'). Packaging standards require measures to prevent contamination and leakage and to preserve integrity. Operationally this requires shippers, couriers, and registrants to redesign shipping workflows and reconcile donor‑identifying labels with privacy obligations.
Permitted disclosures, disposition duties, and penalties
The bill authorizes use and disclosure of individually identifiable donor information only for purposes the Secretary explicitly authorizes by regulation (the text names return of remains as an example). Registrants must return remains to the person with legal control or fulfill written instructions, or contract transferees to assume those obligations. Enforcement tools include criminal fines under title 18 for label alteration or falsification and administrative suspension or revocation of registration for violations; however, the bill does not spell out civil penalty ranges or administrative process details, leaving them to HHS rulemaking.
Definitions and two‑year effective delay
The bill defines donor, education, human body, and human body part and excludes blood drawn for medical purposes and growing cell lines from 'body part.' It also clarifies that 'research' does not include autopsies conducted as part of criminal investigations. A separate clause delays applicability for two years after enactment to give HHS and regulated entities time to implement rules, set fees, and prepare inspection programs.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Donors and donor families — gain stronger provenance, clear documentation that consent was obtained for non‑transplant uses, and statutory obligations on registrants to ensure respectful final disposition or return of remains.
- Academic programs and bona fide research institutions — benefit from clearer standards that distinguish non‑profit educational use from commercial selling and from improved traceability of incoming material, which can reduce reputational risk.
- Researchers and clinicians using donated material — receive better provenance and testing information (e.g., serology, implants, cause of death) that improves safety and reproducibility of educational or research activities.
- Public health and regulators — get statutory inspection authority and mandatory records that improve traceability, facilitate outbreak investigations, and reduce the opacity of cross‑border commercial transactions.
Who Bears the Cost
- For‑profit body brokers and commercial anatomical suppliers — will bear registration and renewal fees, new administrative and recordkeeping costs, labeling/packaging upgrades, and the operational cost of facilitating inspections.
- Small labs, clinics, and couriers that participate in transfer chains — may face increased compliance burdens because regulations require documenting prior possessors and maintaining chain‑of‑custody even where they are not the primary seller.
- HHS and Congress — must absorb rulemaking, inspection, and enforcement responsibilities and either fund them through appropriations or risk under‑funded fee collections (collections remain subject to appropriations law).
- Funeral service providers and state agencies — while exempt for certain activities, they may incur indirect costs responding to information requests, producing records for chain‑of‑custody, or adjusting workflows when transfers intersect with commercial sellers.
Key Issues
The Core Tension
The central tension is between stronger provenance and donor protections on one hand and privacy, operational burden, and federal‑state friction on the other: improving traceability and preventing commercial abuses requires donor identification, record retention, and inspections that can infringe privacy and impose substantial costs on legitimate suppliers and small actors, while federal standardization risks clashing with diverse state disposition laws and well‑established sector practices.
The bill creates a federal overlay on an area historically governed by state anatomical gift laws and sectoral practice. That raises immediate implementation questions: how HHS will harmonize new federal labeling and privacy rules with state disposition statutes, existing anatomical gift frameworks, and HIPAA or state medical privacy rules.
The label checklist requires donor names and sensitive medical details on packages, which improves traceability but creates a privacy risk in transit and during inspections; the statute delegates permitted disclosures to Secretary regulation, so reconciling transparency with confidentiality will be a central rulemaking task.
Practical enforcement depends on funding and regulatory detail. The Secretary sets fees to cover projected implementation and inspection costs, but fee collections can be obligated only when appropriated.
If Congress does not fund the program adequately, HHS may face a gap between statutory responsibilities and capacity to inspect or enforce. The criminalization of label falsification and broad revocation authority give HHS strong tools, but the bill omits civil penalty schedules, procedural safeguards for suspension/revocation, and precise standards for what constitutes 'selling for profit'—leaving significant definitional and due process issues to be resolved in regulation or litigation.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.